Clinical Trial Update: A Study of Treatment With RO6864018 in Virologically Suppressed Participants With Chronic Hepatitis B Virus (HBV) Infection [Phase 2]

View source ↗

Summary

This Phase 2 trial assessed RO6864018 in virologically suppressed participants with chronic hepatitis B; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• RO6864018

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis B, Chronic | Phase 2 | Status: COMPLETED